Abstract
Developing countries face many problems in trying to ensure the accessibility of their populations to pharmaceuticals. The pharmaceutical market has traditionally been a global market. International organisations are trying to help developing countries in addressing the manifold problems posed by the need to make drugs accessible to developing countries’ populations. In the following paragraphs the main problems and the most recent developments affecting that issue are reviewed and discussed.
Get full access to this article
View all access options for this article.
